The University of Vermont received $181.7 million in research funding during the 2020 fiscal year - the largest in UVM history by a wide margin. The Larner College of Medicine had the largest number of grants.

Despite the many challenges academic institutions have faced in 2020, the Vermont Integrative Genetics Resource (VIGR) shared core facility at the University of Vermont Cancer Center and Larner College of Medicine has achieved strong funding support and achieved some significant milestones over the past six months.

Larner College of Medicine faculty members Gregory Holmes, M.D., professor and chair of neurological sciences, and Gary Stein, Ph.D., Perelman professor and chair of biochemistry, have been selected as University Scholars for the 2020-21 academic year.

The American Academy of Arts & Sciences has announced the election of University of Vermont Professor of Microbiology and Molecular Genetics Emerita Susan Wallace, Ph.D., to its membership, in recognition of her status as a world leader in the sciences. Wallace joins 275 new members elected on April 23, 2020.

Over one dozen Larner College of Medicine medical, doctoral students and Master of Public Health degree students recently presented their research alongside hundreds of peers from across UVM for the first-ever virtual Student Research Conference.

Often-deadly blood clots are a common complication of cancer care, yet less than five percent of patients receive education on how to prevent them. A team of clinician-researchers at the UVM Cancer Center have published an evidence-based prevention “roadmap” found to reduce blood clots by 38 percent in the highest-risk patients.

Over the last three weeks, a team of scientists, engineers and doctors at the University of Vermont, including Professor of Medicine Jason Bates, have developed a new design—and built a working model—for a simple, inexpensive ventilator.

Research findings, published in JAMA Network Open and led by University of Vermont Cancer Center researcher Brian Sprague, Ph.D., show that breast cancer screening with digital breast tomosynthesis (also known as 3D mammography) improves breast cancer screening performance among most radiologists.

Glenn Goldman, M.D., professor of medicine and chief of dermatology, was invested as the inaugural Rogers and Nancy Follansbee Professor of Dermatology during a formal ceremony held February 3, 2020 at the Larner College of Medicine at the University of Vermont.

Researchers at the University of Vermont’s Vermont Conversation Lab, including Miller Chair of Palliative Medicine Robert Gramling, M.D., D.Sc., have used machine learning and natural language processing to better understand what conversations surrounding life-threatening and serious illnesses look like, in order to help healthcare providers improve their end-of-life communication. Their work was published December 9 in the journal Patient Education and Counselling.

Two University of Vermont Larner College of Medicine faculty have been named to a list of the world’s most influential researchers, based on the number of times their published studies have been cited by other researchers over the past decade. Researchers on the list are in the top 1 percent of all scholars whose work has been cited. The prestigious Highly Cited Researchers list is compiled and published annually by Clarivate Analytics.

The UVM Health Network is partnering with Invitae and LunaPBC on a pilot project to offer Genomic DNA Testing to patients as part of their clinical care. The pilot program is the beginning of an effort to increase the integration of genetic disease risks into routine medical care, which holds promise for providing Vermonters with valuable information to guide their health decisions.

The Larner College of Medicine's fourth annual "Celebrating Excellence in Research" series featured two days of presentations and recognition designed to highlight research performed by junior faculty, senior faculty, postdoctoral trainees, and graduate students at the College.

It was a beautiful fall day of education and inspiration at the 22nd annual Women’s Health and Cancer Conference. More than 800 patients, providers, exhibitors and family members took part in this one-day, free event.

(JUNE 4, 2019) A breast cancer study published in Radiology and co-authored by Associate Professor of Surgery and Director of the Vermont Breast Cancer Surveillance System Brian Sprague, Ph.D., has been picked up by the newswires and published on multiple websites.

(MAY 22, 2019) In April, the Vermont Department of Health, Vermont Center on Behavior and Health at the Larner College of Medicine at the University of Vermont (UVM), and UVM Cancer Center launched a new longitudinal pilot study, called PACE Vermont (Policy and Communication Evaluation Vermont), which is engaging young people ages 12 to 25 to help close the knowledge gap in effective substance use prevention efforts.

(MARCH 17, 2019) Local Vermont media coverage of the annual S.D. Ireland St. Patrick's Day cement truck parade featured an interview with David Krag, M.D., S.D. Ireland Professor of Surgical Oncology at UVM's Larner College of Medicine, whose research is supported in part by the S.D. Ireland Cancer Research Fund, for which the event is a fundraiser.

Now 15 years old, the Public Health Projects course at the University of Vermont’s Larner College of Medicine has yielded well over 200 projects in partnership with the United Way of Northwest Vermont, dozens of community collaborators and more than 100 professional publications. On January 23, members of the Class of 2021 showcased their work at a Poster Session & Community Celebration.

The Public Health Projects course is 15 years old! Since it first launched in 2004, Larner College of Medicine students have completed 233 projects in partnership with the United Way of Northwest Vermont and dozens of community collaborators and published a total of nine papers and 123 peer-reviewed abstracts, including presentations at the American Public Health Association annual meeting.